Archive · 3 Jun 2025
Zydus Lifesciences Acquires Agenus Manufacturing Units for $125M
Zydus Lifesciences, an Indian company, is buying two factories in California from Agenus, a company that makes medicine, for $125 million.
These factories make important medical products.
This helps Zydus start a new business helping other companies make their products too.
Zydus will also be the only company to make two of Agenus’s cancer treatments.
They will also be allowed to sell these medicines in India and Sri Lanka.
This deal will help Zydus expand its business in the U.S. and create more jobs.
Zydus Lifesciences will acquire two biologics manufacturing facilities from Agenus in California.
The deal is worth $125 million, with $75 million upfront and $50 million in contingent payments.
Zydus will become an exclusive contract manufacturer for Agenus, producing two immuno-oncology products.
Zydus will gain exclusive commercial rights for these products in India and Sri Lanka.
The acquisition allows Zydus to enter the biologics CDMO business and expand in the U.S.
- Who
- Zydus Lifesciences and Agenus Inc.
- What
- Zydus is acquiring two biologics manufacturing facilities for $125 million.
- When
- Announced June 3, 2025
- Where
- The manufacturing facilities are in California, USA.
- Why
- Zydus aims to enter the biologics CDMO business and expand its presence in the U.S. Agenus will receive capital and partnership for manufacturing.
- Buyer
- Zydus Lifesciences
- Seller
- Agenus Inc.
- Facilities Location
- California, USA
- Total Deal Value
- $125 million
- Upfront Payment
- $75 million
- Contingent Payment
- $50 million
- CDMO Role
- Exclusive manufacturer for Agenus
- Commercial Rights
- India and Sri Lanka
